0,1,2,3,4,5,6,7,8
Table 6.3: Adjuvant conventional radiotherapy for node-positive penile cancer,,,,,,,,
Author,n,stage,aRT,"Adj
CT",RT,LR,OS,Study type
"Jaipuria 
2020 [274]",45,"anyT pN2-3
pelvis pN-",25,7,"VMAT/IMRT, 
45 Gy basic, 
54 Gy ENE,
 57-60 macro",No InF,"47 mo. RT
vs. 14 mo. CT","Prosp
registry"
"Johnstone 
2019 [275]",93,"anyTpN3
ENE-
ENE+",,,50/25 no details,,"↑OS aRT 
p = 0.037
or aCT 
p = 0.038
↑DSS aRT 
p = 0.04",4 centres
"Winters 
2018 [280]",136,"pT1-3 
pN1-2",,,"45 Gy + boost 
45%",,"↑OS aRT
5 yr.
64% vs. 53%",NCDB
"Tang 
2017 [277]",92,N3 +pelvis,40,,"63% 50/25, 
13% > 50 Gy",,"↑OS aRT
12.2 vs.8
P=0.04
↑DSS
14.4 vs.8
p = 0.02",4 centres
"Ager 
2021 [276]",146,"pN3 (ENE 
or pelvis+)",121,,"45/20 to 54/25
2X↑LR if < 50",26 inF,"OS 44%
RFS 5y 51%","2 centres 
UK"
"Bandini 
2021 [34]",507,ILND,"86
HPV+
40
aRT",,,,"↑OS aRT
p = 0.015
Also propensity
matched 
analysis",11 centres
